Search for: "BIOGEN INC." Results 81 - 100 of 259
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Federal Circuit Focuses On Active Ingredient, Not Active Moiety, For Scope Of Patent Term Extension
30 Jun 2020, 6:59 am by Courtenay C. Brinckerhoff
Inc. v. [read post]
PharmaPatents - https://www.foley.com/en/insights/blogs/pharmapatents
Metrics and Measurement: What to Track, Why, and How
24 May 2010, 9:11 am by Doug Cornelius
Brooks OfficeMax Inc. [read post]
Compliance Building - http://www.compliancebuilding.com
Supreme Court Certiorari: Summary Dispositions of Classen and Prometheus
29 Jun 2010, 9:19 am by Stephen Albainy-Jenei
Prometheus Laboratories, Inc. v. [read post]
Patent Baristas - http://www.patentbaristas.com
Moore Dissent in Classen
7 Sep 2011, 9:29 am by Stephen Jenei
In Classen Immunotherapies, Inc. v. [read post]
Patent Baristas - http://www.patentbaristas.com
Biogen Int'l GmbH v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2021)
1 Dec 2021, 9:59 pm by Patent Docs
By Kevin E. [read post]
Patent Docs - http://www.patentdocs.org/
Biotech Claims Need to be Tied to a "Particular Machine or Apparatus"
19 Dec 2008, 8:00 pm
In a nonprecedential opinion today, Classen Immunotherapies, Inc. v. [read post]
Patent Baristas - http://www.patentbaristas.com
Ninth Circuit Seeks Guidance From California Supreme Court on Business to Business Non-Competes
23 Mar 2020, 11:05 am by Robert B. Milligan, Lauren Leibovitch and Miguel Ramirez
Apple Inc., 1 Cal. [read post]
Trading Secrets - http://www.tradesecretslaw.com/
PTAB declines to institute IPR against Biogen's US 8,399,514 related to the MS drug Tecfidera
3 Sep 2015, 3:06 pm by Lawrence B. Ebert
EndoPharmaceuticals Inc., 438 F.3d 1123, 1134 (Fed. [read post]
IPBiz - http://ipbiz.blogspot.com/
CAFC grants mandamus, transfer of venue in Sanofi case
24 May 2009, 10:58 pm
In the case IN RE GENENTECH, INC. and BIOGEN IDEC INC., the petitioners sought, and obtained, a writ of mandamus to move the patent case from ED Texas to ND California. [read post]
IPBiz - http://ipbiz.blogspot.com/
Chancery Decision Expands the Court’s Approaches on Director Independence
5 Aug 2022, 6:31 am
(which had recently been spun off from Biogen, Inc.) by Sanofi, S.A. [read post]
The Harvard Law School Corporate Governance Blog - http://blogs.law.harvard.edu/corpgov
Chancery Decision Expands the Court’s Approaches on Director Independence
5 Aug 2022, 6:31 am
(which had recently been spun off from Biogen, Inc.) by Sanofi, S.A. [read post]
Harvard Law School Forum on Corporate Governance - https://corpgov.law.harvard.edu
Trees for the Forest: Claiming Endpoints of a Range and Written Description
30 Nov 2021, 9:36 am by Dennis Crouch
Mylan Pharma Inc. [read post]
Patently-O - http://patentlyo.com/patent
Intercompany Sales From Patentee to Wholly-Owned Subsidiary May Constitute “Sales” for Purposes of Lost Profits
30 Jul 2018, 7:17 am by Docket Navigator
Biogen Idec Inc., 2-10-cv-02734 (NJD July 26, 2018, Order) (Cecchi, MJ) [read post]
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/
Center for Biological Diversity v. U.S. EPA
15 Jul 2013, 1:50 pm by WIMS
[#Climate, #Air, #CADC]Waste Information & Management Services, Inc. [read post]
Environmental - Appeals Court - http://environmentalappealscourt.blogspot.com/
Massachusetts Dangerous Drug Lawsuit Blames Prolonged Use of Tysabri For Brain Disease PML in Patients with Multiple Sclerosis
13 Sep 2013, 8:09 pm
Yout is suing Elan Pharmaceuticals and Biogen Idec Inc. for over $1 million in damages. [read post]
Massachusetts Drug Injury Lawyers Blog - http://www.druginjurylawyersblog.com/
Medical Method Claims Recite Patentable Subject Matter, Prometheus Notwithstanding
12 Aug 2012, 11:47 am by Charles Bieneman
Biogen Idec, No. [read post]
Software Intellectual Property Report - http://swipreport.com/
Tysabri And PML: No New Reports Of Serious Brain Infection PML According To Biogen And Elan
4 May 2007, 2:56 pm
Biogen Idec Inc. and Elan Corp., also said there were no reports of other "serious opportunistic infections," as of April 23. [read post]
Drug Injury Watch - http://www.drug-injury.com/druginjurycom/
Classen wins at CAFC on US '139 and ’739, even tho breadth is not of staggering character
31 Aug 2011, 9:52 am by Lawrence B. Ebert
The conclusion of the CAFC in Classen v Biogen, et al [read post]
IPBiz - http://ipbiz.blogspot.com/
SANDBOX LOGISTICS loses appeal at CAFC over the meaning of "bottom"
18 May 2020, 8:38 am by Lawrence B. Ebert
See Biogen Idec,Inc. v. [read post]
IPBiz - http://ipbiz.blogspot.com/
Patenting Information
1 Dec 2010, 9:59 pm by Patent Docs
Biogen Idec cases by the... [read post]
Patent Docs - http://www.patentdocs.org/